Contineum Therapeutics (CTNM) Q1 2025 Earnings

Mar 6Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-3.55
-2.48
-1.42
-0.35

Details

Expected EPS
-0.428
Actual EPS
-0.56
Surprise EPS
-0.13
Surprise Percent
-30.84%

Description

⁨Contineum Therapeutics⁩ (⁦CTNM⁩) has reported earnings of ⁦-0.56⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts